Pyxis Oncology (PYXS) Non-cash Items (2020 - 2025)

Pyxis Oncology (PYXS) has 6 years of Non-cash Items data on file, last reported at $595000.0 in Q4 2025.

• Non-cash Items for Q4 2025 came in at $595000.0, up 1252.27% year-over-year; the trailing twelve-month figure through Dec 2025 was $595000.0 (up 1252.27% YoY), and the FY2025 annual result was $595000.0, up 1252.27% from the prior year.
• Non-cash Items declined to $595000.0 in Q4 2025 per PYXS's latest filing, from $5.1 million in the prior quarter.
• Over five years, Non-cash Items peaked at $34.8 million in Q3 2021 and troughed at $44000.0 in Q4 2024.
• A 5-year average of $5.0 million and a median of $2.9 million in 2023 frame the typical range for Non-cash Items.
• The sharpest annual moves came in 2021 and 2022: Non-cash Items jumped 4616.67% in 2021, then plunged 99.56% in 2022.
• A 5-year view of Non-cash Items shows it stood at $16.4 million in 2021, then sank by 99.56% to $72000.0 in 2022, then soared by 95.83% to $141000.0 in 2023, then plunged by 68.79% to $44000.0 in 2024, then soared by 1252.27% to $595000.0 in 2025.
• Business Quant data shows PYXS's Non-cash Items at $595000.0 in Q4 2025, $5.1 million in Q3 2025, and $497000.0 in Q2 2025.